Asahikawa Medical University Hospital
Asahikawa, Hokkaido, Japan
National university in Asahikawa
1 Chome-1-1 Midorigaoka Higashi 2 Jo, Asahikawa, Hokkaido 078-8510
About Asahikawa Medical University Hospital
Asahikawa Medical University, Kyokui, or AMU, is a national university and medical school in Asahikawa, Hokkaido, Japan. Established in 1973, the university has one faculty, Faculty of Medicine, consisting of Department of Medicine and Department of Nursing.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Eli Lilly and Company
5
Pfizer
5
Boehringer Ingelheim
3
Janssen Research & Development, LLC
3
Chugai Pharmaceutical
2
Japan Clinical Cancer Research Organization
2
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
2
Abbott Medical Devices
1
Amgen
1
Boston Scientific Corporation
1
Clinical Trials at Asahikawa Medical University Hospital
During the past decade, Asahikawa Medical University Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 14 clinical trials were completed, i.e. on
average, 51.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
2001-03-01
2008-11-01
Completed
Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
2004-04-01
Unknown status
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
2008-03-01
2011-06-01
Completed
300
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
1,111
Small Coronary Artery Treated by TAXUS Liberté Registry in Japan
2009-04-01
2012-08-01
Unknown status
250
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Asahikawa Medical University Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Eli Lilly and Company" with 5 trials
sponsored, "Pfizer" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Janssen Research & Development, LLC"
with 3 trials sponsored. Other sponsors include 14 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Asahikawa Medical University Hospital"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Maruishi Pharmaceutical" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Asahikawa Medical University Hospital
According to Clinical.Site data, the most researched conditions in "Asahikawa Medical University Hospital" are
"Macular Edema" (3 trials), "Psoriasis" (3 trials), "Colorectal Cancer" (2 trials), "Crohn's Disease" (2 trials) and "Diabetic Macular Edema" (2 trials). Many other conditions were trialed in "Asahikawa Medical University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Asahikawa Medical University Hospital
Most popular intervention types in "Asahikawa Medical University Hospital" are "Drug" (32 trials), "Procedure" (5 trials), "Device" (4 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials) and "Guselkumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Asahikawa Medical University Hospital
The vast majority of trials in "Asahikawa Medical University Hospital" are
41 trials for "All" genders.
Clinical Trials Status at Asahikawa Medical University Hospital
Currently, there are NaN active trials in "Asahikawa Medical University Hospital".
undefined are not yet recruiting,
7 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in Asahikawa Medical University Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Asahikawa Medical University Hospital, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".